- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02700061
Effects of Upper Limb Motor and Robotic Training Over Neuroplasticity and Function Capacity (NARLE1)
Effects of Upper Limb Motor Training and Upper Limb Robotic Training Over Neuroplasticity and Function Capacity: A Single-blind Randomized Clinical Trial With Patients With Stroke Sequelae
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The trial is being carried out in the Institute of Physical Medicine and Rehabilitation of the University of São Paulo since February 2012. The investigators are including patients with clinical diagnosis of Ischemic or hemorrhagic stroke.
The patients are being randomized in blocks of four, six and eight, in two arms: ICT: patients are undergoing 60 minutes physiotherapy and occupational therapy twice a week for ten consecutive weeks. Other therapeutic services as phonoaudiology, psychology, nutrition, physical conditioning are prescribed upon the patients' medical demands. After the 10 weeks, the patients are undergoing two whole weeks of daily ICT as to reach 90% of the time under constraint, including weekends. During this last period, no other therapeutic service is offered, but the occupational therapy under ICT. Patients are not allowed to undergo robotic therapy.
Robotic therapy: patients are undergoing robotic occupational therapy for 60 minutes, three times a week for twelve consecutive weeks. All other therapeutic services are prescribed upon the patients' medical demands. Patients are not allowed to undergo ICT.
The investigator and the raters are blind to treatment.
The evaluations are done prior to the beginning of the treatment and at the end of it. The follow up assessments are done at 3 and 12 months after the end of the treatment.
The sample size was estimated to be 62 patients in each arm, a total size of 124 patients
Studientyp
Einschreibung (Tatsächlich)
Phase
- Phase 2
Kontakte und Standorte
Studienorte
-
-
-
Sao Paulo, Brasilien, 04116-040
- Centro de Pesquisa Clínica do Instituto de Medicina Física e Reabilitação do HCFMUSP
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Clinical diagnosis of stroke;
- Patients from 6 months after stroke up to 36 months after stroke;
- Clinically stable;
- Upper limb Brunnstrom scale III or IV;
- Brunnstrom scale above V if clinician supports patients will benefit from treatment;
- Minimum wrist extension of 20°, and minimum of 10° of metacarpophalangeal active extension.
- Signed Informed Consent Form;
Exclusion Criteria:
- Mini-Mental score lower than 20 points;
- Previous multiple strokes;
- Bone diseases and articulation injuries ;
- Presence of psychological disturbances capable of diminishing adherence;
- Articulation pain within the range of motion proposed by the therapies;
- Participation in another study protocol for upper limbs therapies.
- Previous treatment with robotic assisted therapies.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Induced Constraint Therapy - ICT
Physical rehabilitation with Induced Constraint Therapy as part of the occupational therapy.
Standard Occupational Therapy two times a week for ten weeks, followed by two whole weeks of Induced Constraint Therapy.
|
Standard Occupational Therapy two times a week for ten weeks, followed by two whole weeks of Induced Constraint Therapy.
Andere Namen:
|
Experimental: Robotic occupational therapy
Physical rehabilitation with Robotic occupational therapy.
Robotic Occupational Therapy three times a week for twelve weeks.
|
Robotic Occupational Therapy three times a week for twelve weeks.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change on Motor Function assessed by Wolf Motor Function scale
Zeitfenster: Baseline and 12 weeks
|
Change from baseline in Wolf Motor Function scale.
|
Baseline and 12 weeks
|
Change on Motor Function assessed by Fugl Meyer scale
Zeitfenster: Baseline and 12 weeks
|
Change from baseline in Fugl Meyer scale.
|
Baseline and 12 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change on Motor Function assessed by Wolf Motor Function scale
Zeitfenster: Baseline, 3 months and 12 months
|
Multiple changes from baseline in Wolf Motor Function scale.
|
Baseline, 3 months and 12 months
|
Change on Motor Function assessed by Fugl Meyer scale
Zeitfenster: Baseline, 3 months and 12 months
|
Multiple changes from baseline in Fugl Meyer scale.
|
Baseline, 3 months and 12 months
|
Change on Motor Function assessed by Robotic scale
Zeitfenster: Baseline, 3 months and 12 months
|
Multiple changes from baseline in robotic scale.
|
Baseline, 3 months and 12 months
|
Change on Function ability and quality of movement assessed by Arm Motor Ability Test (AMAT)
Zeitfenster: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in AMAT scale.
|
Baseline, 12 weeks, 3 months and 12 months
|
Change on Functional Independence Measure (FIM) as assessed by FIM scale
Zeitfenster: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in FIM scale.
|
Baseline, 12 weeks, 3 months and 12 months
|
Change on Quality of life assessed by Stroke Impact Scale (SIS)
Zeitfenster: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in SIS.
|
Baseline, 12 weeks, 3 months and 12 months
|
Change on Kinematic variables assessed by InMotion robots
Zeitfenster: Baseline, 12 weeks, 3 months and 12 months
|
Multiple motion changes from baseline in the Kinematic variables assessed by InMotion robots.
|
Baseline, 12 weeks, 3 months and 12 months
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Psychological Evaluation assessed by Perceived Stress Scale (PSS-10)
Zeitfenster: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in PSS-10.
|
Baseline, 12 weeks, 3 months and 12 months
|
Neuroplasticity as assessed by Brain Derived Neurotrophic Factor (BDNF)
Zeitfenster: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in BDNF.
|
Baseline, 12 weeks, 3 months and 12 months
|
Corticospinal excitability as assessed by transcranial magnetic stimulation (TMS)
Zeitfenster: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in TMS.
|
Baseline, 12 weeks, 3 months and 12 months
|
Neurologic evaluation as assessed by electroencephalography
Zeitfenster: Baseline, 12 weeks, 3 months and 12 months
|
Multiple changes from baseline in electroencephalography.
|
Baseline, 12 weeks, 3 months and 12 months
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Linamara Rizzo Battistella, Md PhD, University of Sao Paulo
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 0910.0.015.000-11
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Induced Constraint Therapy - ICT
-
Shirley Ryan AbilityLabAbgeschlossenZerebralparese | Hemiplegie | Hemiparese | Sprech- und SprachstörungVereinigte Staaten
-
University of Southern CaliforniaNational Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... und andere MitarbeiterAbgeschlossenSchlaganfall, Herz-KreislaufVereinigte Staaten
-
Shaare Zedek Medical CenterUnbekanntZerebralparese | HemiplegieIsrael
-
University of FloridaNational Institutes of Health (NIH); US Department of Veterans AffairsAbgeschlossenStreicheln | HemiplegieVereinigte Staaten
-
Rockhurst UniversityAbility KCAbgeschlossenHemiplegische Zerebralparese | Nicht unfallbedingte traumatische Kopfverletzung eines Kindes
-
Virginia Polytechnic Institute and State UniversityOhio State University; University of VirginiaAbgeschlossenZerebralparese | Gehirnverletzung | HemipareseVereinigte Staaten
-
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...Abgeschlossen
-
Ohio State UniversityVirginia Polytechnic Institute and State University; Nationwide Children's HospitalAbgeschlossenHemiplegische ZerebralpareseVereinigte Staaten
-
University of Alabama at BirminghamAbgeschlossenChronische Schlaganfall-Überlebende mit plegischer HandVereinigte Staaten
-
Chang Gung Memorial HospitalAbgeschlossen